.jpg){kind=logo}
The rising interest in the field of flow cytometry services is reflected by the number of partnerships inked in the recent past.
The flow cytometry services market (services) is estimated to be worth $2.76 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 9.73% during the forecast period.
During our research, we came across several partnerships and collaborations that have been inked between various stakeholders involved in the flow cytometry domain. This chapter features in-depth analysis and discussion of the various partnerships inked between the players in this market, during the period, 2012-2022 (till June). It is important to highlight that, only those instances where companies have entered into deals related to flow cytometry services market, have been included in this analysis.
Most of the partnership activity in this domain (as reported in the given period of time) is restricted to North America. It is also worth highlighting that close to 38% of the partnerships in this region were intercontinental collaborations while over 62% were intracontinental.
The projected market opportunity is anticipated to be well-distributed across different key-geographical regions.
Innovators in the diagnostics industry have been extensively studying flow cytometry for diagnosis of diseases such as cancers and HIV and for immunological analysis. The motive behind the exploration of this route, is the advantages offered by flow cytometry. These includes multiparametric analysis, rapid and enhanced results. Further, the rising use of flow cytometry for diagnostics and clinical purposes, demonstrate the wide acceptance of flow cytometry as a viable diagnostics option. Therefore, we expect that flow cytometry services market is likely to grow at a significant pace in the foreseen future.
In pursuit of a competitive edge, stakeholders are actively expanding their existing capabilities to enhance their respective offerings and comply with evolving industry benchmarks. The primary purpose of this analysis was to develop a deeper understanding of the overall strength of the service providers involved in this field. It allows companies to compare their existing capabilities within their respective peer groups and identify ways to gain a competitive edge in the industry. In addition, this analysis can be used by the companies to ascertain improvement areas by identifying the gaps between their existing capabilities and the best available practices in the industry.
In this analysis, we have analyzed all the companies and plotted a four-dimensional bubble analysis with supplier strength on the abscissa, service strength on the ordinate and facility strength as the size of the bubble. The primary purpose of this analysis is to compare the popularity and activity of different flow cytometry service providers on a relative basis. At no point, should the discussion in this analysis be construed as a firm recommendation that one service provider is better than the others. It is important to mention that this analysis has been done based on the information collated from various publicly available sources and the information disclosed by the company.
Around 107 flow cytometric facilities are located across the globe with North America being the key hub; flow cytometry service providers are steadily extending their global presence.
Several industry players have established flow cytometry facilities offering flow cytometry services across the world. During our research, we came across North America and Europe, which emerged as the key hub for establishing these facilities. Majority of the service providers have established their facilities in North America; within this region, most of the facilities are located in US, followed by Mexico.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Website: https://www.rootsanalysis.com/
Comments